UCLA Study Says Pomegranates Fight Cancer
While pomegranates have been used medicinally for thousands of years dating back to ancient Babylonia, in recent months several findings concerning the health benefits of pomegranates have made headlines throughout the world. One such study conducted by researchers at UCLA appeared in the The New York Times.
Efficacious and timely with an aging U.S. population and prostate cancer rates on the rise, a distinctive new line of pomegranate-based supplements called Pomology™ is now available.
Along with leading nutritionists and fitness experts, the company has developed five highly-beneficial pomegranate-based formulas for specific functions and conditions: Heart Health; Prostate PM; Menopause; Joint and Antioxidant Health. Each product contains a premium blend of proven ingredients that consumers can utilize for immediate relief and long-term preventative benefits. Pomegranate, blueberry, cranberry, grapeseed, green tea and broccoli are just some of the all-natural antioxidants contained in Pomology products.
Pomegranates are known to have anti-inflammatory effects and high levels of antioxidants, which are believed to protect the body from free-radical damage. They also contain poly-phenols, natural antioxidant compounds found in green tea, as well as isoflavones commonly found in soy, and ellagic acid which is believed to play a role in cancer cell death. Pomegranate (Punica granatum) is native to a region ranging from Iran to the Himalaya. It later spread to the Mediterranean area and now grows in most of the United States.
Pomology was founded in 2005 by a team of renowned nutritionists and athletic performance experts who saw the need for nutraceuticals that combined the benefits of the latest medical research with the long-term building blocks of good health found in all-natural antioxidants. Pomology combines these ingredients in formulas that meet people’s varying lifestyle needs – resulting in a product line of the highest quality and efficacy.